PCI Pharma Services Acquires Bellwyck Pharma Services

February 11, 2020

PCI Pharma Services announced the acquisition of Bellwyck Pharma Services, a Toronto-headquartered clinical and commercial packaging, labeling and clinical trial services provider. The deal adds four GMP-compliant facilities in the U.S., Germany and Canada to PCI's global network and expands PCI's clinical trial service footprint into Canada and continental Europe.

Buyers
PCI Pharma Services
Targets
Bellwyck Pharma Services
Location
Ontario, Canada
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.